Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_provenance.
- NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_assertion description "[In addition, the combination of AICAr with antifolates [methotrexate (MTX) or pemetrexed] has been shown to further potentiate AMPK activation and to lead to greater cytotoxicity and growth inhibition in leukemia and other malignant cell types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_provenance.
- NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_assertion evidence source_evidence_literature NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_provenance.
- NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_assertion SIO_000772 21262957 NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_provenance.
- NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_assertion wasDerivedFrom befree-20140225 NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_provenance.
- NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_assertion wasGeneratedBy ECO_0000203 NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP788404.RAP2qbsCwU4XaHWmlMkAcCTLVmVvl9qJjuRtFIYDT18hU130_provenance.